Skip to content
-
Oncoinvent ASA: New share capital registered
-
Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology
-
Oncoinvent ASA: Notification of trade – primary insider/close associate
-
Oncoinvent ASA: Resolution to increase the share capital in connection with settlement of underwriting fee
-
Oncoinvent ASA: Minutes from Extraordinary General Meeting
-
Oncoinvent ASA: Notification of trade – primary insider/close associate
-
Oncoinvent ASA: Final results of the rights issue
-
Oncoinvent ASA: Preliminary results of the rights issue
-
Oncoinvent ASA: Last day of the subscription period in the rights issue
